Shiitake is an edible mushroom and oral supplement used to support immune defense and healthy blood fat levels. Human evidence for oral use is modest and mixed: whole mushrooms moderately lower blood triglycerides and shift white blood cells and salivary antibodies, whereas concentrated extracts show inconsistent effects. Thorough cooking and dicing prevent a temporary whip-like skin rash, elevated allergy-related white blood cells, and intestinal blockage. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting Serum Triglycerides | No established target (percentage reduction from baseline) | Expected to change: evaluates whether oral shiitake reduces circulating triglycerides |
| High-Sensitivity C-Reactive Protein (hs-CRP) | No established target (reduction from baseline) | Expected to change: assesses systemic inflammatory modulation reported with daily whole-mushroom intake |
| Salivary Secretory Immunoglobulin A (sIgA) | No established target (increase from baseline) | Expected to change: monitors mucosal immune response during daily dietary or β-glucan intake |
| Absolute Blood Eosinophil Count | 0–400 cells/mm3 (standard reference range) | Safety check: detects shiitake-induced blood eosinophilia that warrants stopping supplementation |
Cadence: Baseline fasting lipid panel, hs-CRP, salivary sIgA, and complete blood count (CBC) with differential prior to initiation; CBC with differential repeated at 4 weeks (for unheated powders or high-dose extracts); fasting triglycerides, hs-CRP, and salivary sIgA assessed at 8–12 weeks and every 6 months thereafter.